Palantir's $250 Target Is Real Demand — and a Price the Market Already Pays

The call that moved Palantir shares this week was a number with no model behind it. D.A. Davidson lifted its price target to $250, up from $200, while keeping a Buy on the stock — roughly 51% above where the shares trade. But lift the hood on any target and you find the same thing: a multiple someone is willing to keep paying, carried one year forward. The useful question is not whether Palantir can hit $250. It is what $250 actually assumes, and whether the business is proving the part of the story that matters.

Start with the reason the firm raised the number, because it is real. Palantir's eleventh AIP conference was built around "AI sovereignty," and management says the idea is gaining traction with customers. The pitch is simple to grasp: an enterprise should own and control its own data, its own fine-tuned models, and the operational layer on top of them, rather than hand everything to an outside model provider. Palantir frames this as protecting the part of a business that is more valuable than the raw data — the reasoning traces and operational knowledge its software accumulates as it runs. The partnership D.A. Davidson highlighted — a supply-management system Palantir built for Nvidia — is a concrete example of the same idea selling into real operations.

That is plenty to hang a story on. But my discipline is to check the cash-flow path before the excitement, and here it is exceptional. In the second quarter, revenue rose 93% year over year to $1.935 billion, and U.S. commercial revenue was up 149% to $764 million. Adjusted free cash flow came in at $1.22 billion for the quarter — a 63% margin. Net income was $1.06 billion on GAAP, a 55% margin. The company raised full-year guidance to $8.15–$8.158 billion in revenue, about 82% year-over-year growth, and guided to $4.5–$4.7 billion in adjusted free cash flow. The forward-looking part is just as strong: U.S. commercial contract value signed in the quarter grew 153% to $2.13 billion, and the "remaining deal value" for U.S. commercial customers — work already committed under contracts but not yet counted as revenue — grew 124% to $6.24 billion.

That last number matters most. Backlog growing at triple digits is the proof that revenue isn't a one-quarter trick: it is already locked, waiting to be recognized. For a story hinge, that is about as clean as free cash flow gets. Palantir is a genuinely excellent business doing the hard thing — converting a narrative into committed dollars and turning them into cash.

Now the uncomfortable half. None of that is a surprise, and none of it is cheap. At roughly $166 a share the company carries a market capitalization around $399 billion against about 2.4 billion shares. Against this year's raised guidance of $8.15 billion in revenue, that is about 49 times forward sales. Against the $4.6 billion midpoint of adjusted free cash flow guidance, it is roughly 87 times forward free cash flow and about 82 times projected adjusted operating income. This is not an expectations reset — the marketplace already believes the story with conviction, and the price is asking for continued perfection.

So what does the $250 target really say? Multiply $250 by the same share count and you get a ~$600 billion market capitalization — about 74 times this year's revenue and roughly 130 times this year's projected free cash flow. The target is not a new insight into the company. It is the same enormous multiple the market already pays, transferred to a larger set of numbers that are still growing quickly. It works as an investment thesis only while the trajectory keeps compounding at breakneck speed. If U.S. commercial backlog and contract value stop compounding — if 124% and 153% growth become, say, 30% — there is nowhere for that multiple to hide, because the entire base is built on the pace of the trajectory, not on current dollars that could justify it in a normal year.

That is the tripwire, and it is the honest core of the case. The business proof is real and verified, so this is not a thesis to dismiss on valuation alone — the tape and the numbers are aligned rather than diverging. But it is also not a beaten-down setup where expectations have reset and surprise is cheap. It is the mirror image: the market has already taken the optimistic view, and the $250 call makes that view bolder rather than resolving it.

For a holder or a buyer, the decision comes down to whether you can tolerate giving the market credit for years of success you have not actually seen yet. I can be wrong again — and if U.S. commercial backlog keeps compounding at triple digits and free cash flow keeps converting at 60% margins, the skeptics are the ones who look foolish. But the proof path here is not "does Palantir get better." It is "does the trajectory stay this good," and that is a much harder bar to clear from a ~$400 billion starting point than it is to announce.